MedPath

VANDERBILT UNIVERSITY MEDICAL CENTER

VANDERBILT UNIVERSITY MEDICAL CENTER logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1925-01-01
Employees
10K
Market Cap
-
Website
http://www.vumc.org

Autonomic Determinants of POTS - Pilot 2

Early Phase 1
Recruiting
Conditions
Postural Tachycardia Syndrome
Interventions
Drug: Placebo oral tablet
Drug: Moxonidine Pill
First Posted Date
2019-10-28
Last Posted Date
2024-01-29
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
48
Registration Number
NCT04140721
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Effects of Exercise on Glymphatic Functioning and Neurobehavioral Correlates in Parkinson's Disease

Not Applicable
Completed
Conditions
Parkinson's Disease and Parkinsonism
Glymphatic System
Interventions
Behavioral: Exercise--Rock Steady Boxing class
First Posted Date
2019-10-28
Last Posted Date
2024-01-05
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
28
Registration Number
NCT04140708
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Pediatric Type 1 Diabetes and Neurocognitive Complications Cohort Study

Completed
Conditions
Type 1 Diabetes
Interventions
Behavioral: neurocognitive assessment
Behavioral: neuroimaging assessment
First Posted Date
2019-10-22
Last Posted Date
2022-11-01
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
12
Registration Number
NCT04135365
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

A Clinical Trial Utilizing Dantrolene in Patients with Ventricular Arrhythmias.

Phase 2
Active, not recruiting
Conditions
Ventricular Tachycardia
Interventions
Drug: Dantrolene/Ryanodex
Drug: Placebo
First Posted Date
2019-10-22
Last Posted Date
2024-12-18
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
84
Registration Number
NCT04134845
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 1
Interventions
Other: Standard Carb Diet
Other: Low Carb Diet
First Posted Date
2019-10-08
Last Posted Date
2024-10-04
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
12
Registration Number
NCT04118374
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Combinatorial Single Cell Strategies for a Crohn's Disease Gut Cell Atlas

Active, not recruiting
Conditions
Crohn Disease
Interventions
Other: Sample Collection
First Posted Date
2019-10-03
Last Posted Date
2024-10-26
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
178
Registration Number
NCT04113733
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2

Phase 4
Recruiting
Conditions
Heart Failure
Interventions
First Posted Date
2019-10-02
Last Posted Date
2024-03-05
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
80
Registration Number
NCT04113109
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Activity Monitoring in Pulmonary Hypertension

Recruiting
Conditions
Pulmonary Hypertension
Interventions
Behavioral: Activity Monitoring
First Posted Date
2019-09-24
Last Posted Date
2023-09-26
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
500
Registration Number
NCT04101630
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Evaluating the Impact of the Bridge Clinic in Patients With Opioid Use Disorder

Not Applicable
Completed
Conditions
Opioid Use
Opioid-use Disorder
Interventions
Other: Usual Care
Other: Bridge Clinic
First Posted Date
2019-09-10
Last Posted Date
2024-07-10
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
335
Registration Number
NCT04084392
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Senescent Immunity in Elders and Vaccine Responses (SILVER)

Phase 4
Completed
Conditions
Flu Vaccine
Interventions
Biological: Flublock
Biological: Fluzone-High Dose Quadrivalent
Biological: Fluad
First Posted Date
2019-09-04
Last Posted Date
2022-07-12
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
10
Registration Number
NCT04077424
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath